Literature DB >> 12625845

Pharmacology of phosphodiesterase 5 inhibitors.

Serge Carrier1.   

Abstract

The phosphodiesterase enzymes, of at least 11 types, are ubiquitous throughout the body, and perform a variety of functions. Phosphodiesterase type 5 (PDE5) is the predominant enzyme in the corpus cavernosum, and plays a crucial role in penile erection. Inhibitors of PDE5 are the most effective oral agents in the treatment of erectile dysfunction. Sildenafil, tadalafil, and vardenafil are all potent inhibitors of PDE5 and show the same mechanism of action, although they have some pharmacological differences that may translate into varying clinical effects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12625845

Source DB:  PubMed          Journal:  Can J Urol        ISSN: 1195-9479            Impact factor:   1.344


  4 in total

Review 1.  Phosphodiesterase-5 (PDE5) Inhibitors In the Management of Erectile Dysfunction.

Authors:  Sharon A Huang; Janette D Lie
Journal:  P T       Date:  2013-07

2.  Effect of the phosphodiesterase 5 inhibitors sildenafil, tadalafil and vardenafil on rat anococcygeus muscle: functional and biochemical aspects.

Authors:  Haroldo A Toque; Fernanda B M Priviero; Saiprasad M Zemse; Edson Antunes; Cleber E Teixeira; R Clinton Webb
Journal:  Clin Exp Pharmacol Physiol       Date:  2008-10-15       Impact factor: 2.557

Review 3.  Avanafil for erectile dysfunction in elderly and younger adults: differential pharmacology and clinical utility.

Authors:  Eric G Katz; Ronny Bw Tan; Daniel Rittenberg; Wayne J Hellstrom
Journal:  Ther Clin Risk Manag       Date:  2014-08-27       Impact factor: 2.423

4.  Efficacy and Safety of Mirodenafil Oro-Dispersible Film in Korean Patients with Erectile Dysfunction: A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter, Phase IV Study.

Authors:  Sung Won Lee; Hwancheol Son; Seung Wook Lee; Kang Su Cho; Du Geon Moon; Dae Yul Yang; Woo Sik Chung; Jun-Kyu Suh; Hyun Jun Park; Kweonsik Min; Ki Hak Moon; Kwangsung Park; Jong Kwan Park; Jae Seog Hyun; Sang-Kuk Yang
Journal:  World J Mens Health       Date:  2021-01-21       Impact factor: 5.400

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.